Source: Health Canada shortage reports · Updated Jul 29, 2026
Some Capecitabine products are in shortage in Canada (1 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.
A chemotherapy medication used to treat cancers such as breast and colorectal cancer.
Products affected
1 / 14
In shortage since
Mar 12, 2026
Est. full return
Jul 31, 2026
Reports on file
52
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
CAPECITABINE
500MG · TABLET · JAMP PHARMA CORPORATION
DIN 02519887 · since Mar 12, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CAPECITABINE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02421925 · ended Jan 8, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
150MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457490 · ended Dec 18, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
150MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457490 · ended Dec 16, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
500MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457504 · ended Nov 5, 2025 · Disruption of the manufacture of the drug.
Resolved
CAPECITABINE
150MG · TABLET · SANIS HEALTH INC
DIN 02514982 · ended Sep 3, 2025 · Disruption of the manufacture of the drug.
Resolved
CAPECITABINE
500MG · TABLET · SANIS HEALTH INC
DIN 02514990 · ended Sep 3, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
500MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457504 · ended Jul 24, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
500MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457504 · ended Jun 4, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
150MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457490 · ended Apr 16, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CAPECITABINE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02421925 · ended Feb 17, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CAPECITABINE
150MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02421917 · ended Dec 16, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 52 reports. All reports are on file with Health Canada.
What's happening
Capecitabine is currently affected by an active shortage report filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Capecitabine is classified under “ANTIMETABOLITES” (ATC L01BC).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Jun 26, 2026 → Jul 31, 2026
Common questions
What is Capecitabine used for?
A chemotherapy medication used to treat cancers such as breast and colorectal cancer.
When will Capecitabine be back in stock in Canada?
The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Capecitabine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.